Phenylenediamine urotensin-II receptor antagonists and CCR-9...

Details Phenylenediamine urotensin-II receptor antagonists and CCR-9... Phenylenediamine urotensin-II receptor antagonists and CCR-9...

2007-08-22

2009-08-25

Shiao, Rei-Tsang (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S231500, C514S326000, C514S422000, C514S444000, C544S146000, C546S213000, C548S527000, C548S950000, C549S059000, C549S060000

Reexamination Certificate

active

07579340

ABSTRACT:
The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

REFERENCES:
patent: 5019587 (1991-05-01), Von der Saal et al.
patent: 5932599 (1999-08-01), Godel et al.
patent: 5962490 (1999-10-01), Chan et al.
patent: 5998439 (1999-12-01), Maynard et al.
patent: 6335334 (2002-01-01), Schindler et al.
patent: 6395759 (2002-05-01), Thompson et al.
patent: 6420567 (2002-07-01), Wu et al.
patent: 6632839 (2003-10-01), Neumann
patent: 2005/0049286 (2005-03-01), Wu et al.
patent: 0 344 634 (1989-05-01), None
patent: 0 533 266 (1992-09-01), None
patent: 0 533 267 (1992-09-01), None
patent: 0 533 268 (1992-09-01), None
patent: 0 815 861 (1998-01-01), None
patent: 1 104 763 (1999-08-01), None
patent: WO 94/22807 (1994-10-01), None
patent: WO 98/13366 (1998-04-01), None
patent: WO 00/27820 (2000-05-01), None
patent: WO 01/49289 (2001-07-01), None
patent: WO 02/28353 (2002-04-01), None
patent: WO 03/099773 (2003-12-01), None
patent: WO 2004/045092 (2004-06-01), None
Papadakis et al. “CC Chemiokine Receptor 9 Expression Defines a Subset of Peripheral Blood Lymphocytes with Mucosal T Cell Phenotype and Th1 or T-Regulatory 1 Cytokine Profile” The Journal of Immunology, 2003, vol. 171, No. 1, pp. 159-165.
Silverman, R.B., “The Organic Chemistry of Drug Design and Drug Action” 1992, 15-22.
Wu, et al., “Endothelin Antagonists: Substituted Mesitylcarboxamides with High Potentcy and Selectivity for ETAReceptors”, J. Med. Chem. 1999, 42, 4485-4499.

Affiliated with

Also associated with

Rating

Phenylenediamine urotensin-II receptor antagonists and CCR-9... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylenediamine urotensin-II receptor antagonists and CCR-9..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylenediamine urotensin-II receptor antagonists and CCR-9... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4069449